| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Former 10% Owner
1 company
Euclidean Capital LLC is a 10% Owner at PMV Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 30 sells.
Estimated insider holdings value: $144K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2021 | PMVP Pmv Pharmaceuticals, Inc. | 10% Owner | Sell | 66,396 | $34.01 | $2,257,954.69 | -0.7% | -16.5% | -72.3% | |
| Jun 10, 2021 | PMVP Pmv Pharmaceuticals, Inc. | 10% Owner | Sell | 60,271 | $33.31 | $2,007,708.76 | -0.7% | -12.1% | -70.5% | |
| Jun 8, 2021 | PMVP Pmv Pharmaceuticals, Inc. | 10% Owner | Sell | 62,445 | $33.50 | $2,091,787.14 | -0.7% | -13.0% | -69.1% |